LOADING

2 Bay Area biotechs raise nearly $460M in target-topping IPOs

Two more Bay Area biotech companies raised more than expected Friday ... Ventures (20.7%), Foresite Capital (7.5%) and Bristol-Myers Squibb Co.

More

BB BIOTECH AG: Innovative biotech companies lead efforts in global challenge

DGAP-News: BB BIOTECH AG / Key word(s): Interim Report 24.07.2020 / 07:00 ... Bristol-Myers Squibb - CVR 0.1% Alder Biopharmaceuticals - CVR ...

More

Biotech Stock Roundup: BIIB Reports Q2, GILD Acquires Stake in Private Company & More

Bristol-Myers' Application Gets EMA Validation: Bristol-Myers BMY announced that the European Medicines Agency (EMA) has validated the ...

More

How to price the IP rights underpinning disruptive biotech innovation

Celgene was acquired in 2019 by Bristol-Myers Squibb for $74 billion. The catalyst for these large valuations of gene therapy companies was the ...

More
How to price the IP rights underpinning disruptive biotech innovation

Celgene was acquired in 2019 by Bristol-Myers Squibb for $74 billion. The catalyst for these large valuations of gene therapy companies was the ...

More
French Drugmaker Sanofi eyes Approval Of Potential COVID-19 Vaccine By First-half Of 2021

In an official press release on the website, Sanofi emphasized that Translate Bio would receive over $425 million as upfront payment and common ...

More
New Proprietary Strategies Aimed At Fight Against Pandemic and Inflation

While ultra-relevant in our current pandemic, Biotechnology has notably ... Learn more at www.orion.com or follow news and insights via our blog.

More
Boehringer Ingelheim to cash out Hikma stake; Breast cancer biotech sets terms for IPO

And today, during R&D day, Sanofi CEO Paul Hudson as well as R&D chief John Reed hope to leave that all behind with a forceful presentation on the ...

More